Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. IntelliCentrics Global Holdings Ltd.
  6. News
  7. Summary
    6819   KYG480041089

INTELLICENTRICS GLOBAL HOLDINGS LTD.

(6819)
  Report
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

IntelliCentrics : Launches Patient-Centric Visitor Management Transforming Healthcare Across China, North America, and the UK

03/07/2021 | 08:31pm EDT

Putting patients in control of visitor management in the healthcare setting, IntelliCentrics’ BioBytes™ radically improves safety and security for all while dramatically lowering costs for all locations of care

IntelliCentrics (6819.HK), the innovator of the SEC³URE Ethos, SEC³URE Passport, Link & GO!, BioBytes™ and now BioBytes™ Visitor, serves healthcare facilities across North America, the United Kingdom, and China, announces the creation of another industry first, BioBytes Visitor. BioBytes Visitor delivers value on two concurrent vectors by giving patients control over who can visit them when receiving care while providing locations of care (LOCs) with the ability to apply their safety and COVID-19 policies to visitors. The result is the first-ever technology platform to support the needs of every individual entering an LOC.

“The ability to trust patient visitors is uniquely important for three strategic reasons. Firstly, every year there are literally hundreds of millions of untrusted and unwelcome patient visitors entering our LOCs, compromising everyone’s safety and security. Secondly, COVID-19 taught us the most well-intended visits from family and friends can only happen with trust, at the right time and the right way. Thirdly, BioBytes Visitor is the ideal gateway for visitors to learn about our BioBytes telehealth solution which more deeply connects patients with family, friends and physicians,” said Michael Sheehan, CEO of IntelliCentrics.

IntelliCentrics’ Ethos is the first of its kind technology platform serving both the supply and demand sides of healthcare on a single, integrated, end-to-end technology platform. BioBytes delivers the portfolio of technologies serving the demand side of healthcare and integrates patients with their families and friends with the supply side of healthcare in a safe and trusted way.

“Each of our global markets continues to evolve, but they all demonstrate a large appetite for transformational healthcare technologies. By adding patient-centric visitor management to BioBytes, we believe that we can close the loop, offering a more deeply connected, trusted relationships in the healthcare journey,” continued Sheehan.

About IntelliCentrics
With a mission to use trust to make high-quality healthcare as accessible as a good cup of coffee, IntelliCentrics created the SEC³URE Ethos. Built on three core principles – transparency, neutrality, and independence, the SEC³URE Ethos is relied on by more than 11,000 locations of care worldwide to ensure mutual trust between patients, doctors, vendor representatives and healthcare companies. To learn more about the world’s largest trusted healthcare technology platform, visit www.intellicentrics.com. IntelliCentrics is publicly traded on The Stock Exchange of Hong Kong Limited under the stock code 6819.


ę Business Wire 2021
All news about INTELLICENTRICS GLOBAL HOLDINGS LTD.
09/29Intellicentrics Global Holdings Ltd. Announces Unaudited Consolidated Earnings Results ..
CI
09/21INTELLICENTRICS GLOBAL : to Swing to Loss in FY21
MT
09/20IntelliCentrics Global Holdings Ltd. Provides Earnings Guidance for the Twelve Months E..
CI
07/22INTELLICENTRICS GLOBAL : Partially Recovers Funds Lost in Cyberattack
MT
07/13INTELLICENTRICS GLOBAL : Falls Victim to Social Engineering Crime
MT
06/22INTELLICENTRICS GLOBAL : Exercises Right to Redeem Additional $10 Million Promissory Notes
MT
06/20IntelliCentrics Global Holdings Ltd Announces Partial Redemption of Promissory Notes
CI
04/26INTELLICENTRICS GLOBAL : Voluntary announcement - partial redemption of promissory notes
PU
04/20INTELLICENTRICS GLOBAL : Voluntary announcement - partial redemption of promissory notes
PU
03/11INTELLICENTRICS GLOBAL : Interim report 2020
PU
More news
Financials (USD)
Sales 2021 37,7 M - -
Net income 2021 -2,88 M - -
Net cash 2021 8,20 M - -
P/E ratio 2021 -180x
Yield 2021 -
Capitalization 382 M 382 M -
EV / Sales 2020 7,02x
EV / Sales 2021 13,5x
Nbr of Employees 158
Free-Float 28,5%
Chart INTELLICENTRICS GLOBAL HOLDINGS LTD.
Duration : Period :
IntelliCentrics Global Holdings Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INTELLICENTRICS GLOBAL HOLDINGS LTD.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Managers and Directors
Michael James Sheehan Chief Executive Officer & Executive Director
Alpha Chen Chief Financial Officer
Tsung Liang Lin Chairman
Yu Tien Hsieh Independent Non-Executive Director
Man Chung Wong Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
INTELLICENTRICS GLOBAL HOLDINGS LTD.4.00%400
MICROSOFT CORPORATION39.43%2 313 408
SEA LIMITED72.60%192 327
ATLASSIAN CORPORATION PLC81.52%108 433
ZOOM VIDEO COMMUNICATIONS, INC.-17.38%83 133
DASSAULT SYSTÈMES SE41.86%71 439